MacroGenics
MGNX
#8419
Rank
A$0.32 B
Marketcap
A$5.10
Share price
4.65%
Change (1 day)
156.97%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of September 2025 : A$94.87 Million

According to MacroGenics's latest financial reports the company has A$94.87 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.18 B-16.7%
2023-12-31$A$0.22 B7.34%
2022-12-31$A$0.20 B-36.86%
2021-12-31$A$0.33 B-14.11%
2020-12-31$A$0.38 B16.82%
2019-12-31$A$0.32 B-4.46%
2018-12-31$A$0.34 B-10.05%
2017-12-31$A$0.38 B2.8%
2016-12-31$A$0.37 B-13.32%
2015-12-31$A$0.43 B190.23%
2014-12-31$A$0.14 B67.51%
2013-12-31$A$88.47 M-1216.12%
2012-12-31$-A$7.93 Million-53.52%
2011-12-31$-A$17.06 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$122.87 B 129,412.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.57 B 39,503.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.25 B 12,822.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$32.02 B 33,657.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$74.56 B 78,498.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$26.20 B 27,520.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.89 B 848.62%๐Ÿ‡บ๐Ÿ‡ธ USA